ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Madagascar Female Condom Study

This study has been completed.

Sponsors and Collaborators: Family Health International
Ministry of Health, Madagascar
National Reference Laboratory, Madagascar
University of North Carolina
Information provided by: Family Health International
ClinicalTrials.gov Identifier: NCT00272974
  Purpose

The study was designed to measure the effects of male and female condom promotion on STI prevalence and reported condom use by sex workers and their partners. It also examined whether the intensity of the education and support given to intended users affected adoption and sustained use of these methods.

The primary objective of the study was:

  1. To test the effect of supplementing community-based male and female condom promotion with clinic-based counseling, measured in terms of the level of protection in high-risk sex acts and STI prevalence.

    Secondary objectives of the study included:

  2. To monitor short- and medium terms changes in the proportion of protected sex acts among commercial sex workers after the female condom is added to a male condom distribution system.
  3. To examine short-term and medium-term changes in STI prevalence when the female condom is added to the male condom distribution system.
  4. To measure the incremental cost-effectiveness of adding female condom promotion to existing male condom distribution systems

Condition Intervention Phase
Sexually Transmitted Diseases
Behavioral: Clinic-based counseling
Phase III

MedlinePlus related topics:   Sexually Transmitted Diseases   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Educational/Counseling/Training, Randomized, Open Label, Active Control, Parallel Assignment
Official Title:   Measuring the Impact of Male and Female Condom Promotion Among Commercial Sex Workers in Madagascar

Further study details as provided by Family Health International:

Primary Outcome Measures:
  • Use of protection (male and female condoms)
  • STIs

Estimated Enrollment:   1000
Study Start Date:   February 2001
Estimated Study Completion Date:   August 2003

Detailed Description:

This three-phased study examined ways to improve services for the prevention of STIs among commercial sex workers. This study was conducted in identical fashion in two sites (Tamatave and Antananarivo) in Madagascar. It tested whether condom promotion through community-based counseling or clinic based counseling leads to an increased level of protection among high-risk sex acts and a subsequent decrease in STI infection rates.

In Phase I, women at each site were randomly assigned to a study arm receiving a community-based male condom promotion intervention, or a study arm receiving community-based male condom promotion supplemented with clinic-based counseling. Randomization was accomplished by the use of sequentially-numbered sealed, opaque envelopes containing the group assignment. The randomization list was stratified by study site. Phase I began with baseline measurement of male condom use and STI prevalence. Participants returned three times, at two month intervals, for follow-up. At each visit, face-to-face interviews were conducted to estimate the proportion of protected sex acts. At the third visit only, participants were tested for gonococcal, chlamydial, and trichomonal infections. This reliance on a combination of biologic and behavioral outcomes helped to reduce any bias brought on by the inherent limitations of either of these measures on its own.

Half the women completing Phase I at each site were then randomized to a Phase II study arm receiving a community-based male and female condom promotion intervention, while the other half entered Phase II receiving the same community-based male and female condom promotion supplemented with clinic-based counseling. This sequential randomization scheme allowed measurement of the short-term (within 6 months) effect of clinic-based counseling on male condom use and STI prevalence, and the short-term effect of clinic-based counseling on male condom + female condom use and STI prevalence. A similar data collection process was used, with measurement of male and female condom use in all three visits, and STI testing in the third visit only.

In Phase III, participants were followed for an additional 6 months, in the same intervention group to which they were assigned at the beginning of Phase II, to assess the medium-term impacts of the female condom, after participants had a chance to become accustomed to the female condom.

  Eligibility
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria: Adult female sex workers from the two sites

Exclusion Criteria: None specified

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00272974

Locations
Madagascar
Isotry Health Center    
      Antananarivo, Madagascar
Dispensaire Kelly    
      Tamatave, Madagascar

Sponsors and Collaborators
Family Health International
Ministry of Health, Madagascar
National Reference Laboratory, Madagascar
University of North Carolina

Investigators
Study Chair:     Theresa Hatzell, PhD, MPH     Family Health International    
Study Director:     Paul Feldblum, PhD     Family Health International    
Principal Investigator:     Kathleen Van Damme, MD     Family Health International    
  More Information

Related Info  This link exits the ClinicalTrials.gov site
 

Study ID Numbers:   9713
First Received:   January 4, 2006
Last Updated:   January 4, 2006
ClinicalTrials.gov Identifier:   NCT00272974
Health Authority:   United States: Federal Government

Keywords provided by Family Health International:
AE adverse event  
DCF data collection forms  
IRB Institutional Review Board  
SAE serious adverse event  

Study placed in the following topic categories:
Genital Diseases, Female
Virus Diseases
Sexually Transmitted Diseases
Genital Diseases, Male

Additional relevant MeSH terms:
Infection

ClinicalTrials.gov processed this record on September 04, 2008




Links to all studies - primarily for crawlers